A 5-day outpatient regimen of azacitidine is effective and well tolerated in patients with acute myeloid leukemia unsuitable for intensive chemotherapy

被引：0
|
作者：
O'Reilly, Maeve A. [1 ]
McHale, Cathy [2 ]
Almazmi, Ahmed [1 ]
Hameed, Abdul [3 ]
Benjamin, Dalia [3 ]
O'Connell, Niamh [2 ]
Murphy, Philip [1 ]
Quinn, John [1 ]
Thornton, Patrick [1 ]
O'Gorman, Peter [3 ]
Frankova, Hana [4 ]
Sargent, Jeremy [1 ]
Verburgh, Estelle [3 ]
McHugh, John [2 ]
Evans, Pamela [2 ]
Enright, Helen [2 ]
机构：
[1] Beaumont Hosp, Dept Haematol, Dublin 9, Ireland
[2] Natl Childrens Hosp, Adelaide & Meath Hosp, Dept Haematol, Dublin, Ireland
[3] Mater Misericordiae Univ Hosp, Dept Haematol, Dublin 7, Ireland
[4] Letterkenny Gen Hosp, Dept Haematol, Letterkenny, Ireland
来源：
LEUKEMIA & LYMPHOMA | 2014年 / 55卷 / 12期
关键词：
D O I：
10.3109/10428194.2014.904512
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2950 / 2951
页数：2
相关论文
共 50 条
  • [1] EXPERIENCE OF A 5-DAY SCHEDULE OF AZACITIDINE IN A SINGLE-CENTRE ACUTE MYELOID LEUKEMIA POPULATION
    Fiallo, D.
    Luzardo, H.
    Suarez, A.
    Jimenez, S.
    Campo, C.
    Lopez, J.
    Guerra, L.
    Lemes, A.
    Perera, M.
    Navarro, D.
    Gomez, M.
    Molero, T.
    [J]. HAEMATOLOGICA, 2012, 97 : 506 - 506
  • [2] ACUTE MYELOID LEUKEMIA IN PATIENTS 70 AND ABOVE. AZACITIDINE VERSUS INTENSIVE CHEMOTHERAPY
    De La Fuente, A.
    Deben, G.
    Bargay, J.
    Garrido, A.
    Serrano, J.
    Salamero, O.
    Bergua, J.
    Colado, E.
    Garcia, R.
    Pedro, C.
    Redondo, S.
    Tormo, M.
    Bonanad, S.
    Diez-Campelo, M.
    Perez-Encinas, M.
    Xicoy, B.
    Falantes, J.
    Font, P.
    Gonzalez-Lopez, T.
    Martin, G.
    de Ona, R.
    Montesinos, P.
    Ramos, F.
    [J]. HAEMATOLOGICA, 2014, 99 : 32 - 32
  • [3] Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
    Xia, Leiming
    Tian, Wanlu
    Zhao, Yiming
    Jiang, Lingling
    Qian, Wei
    Jiang, Lei
    Ge, Ling
    Li, Jianjun
    Jin, Fengbo
    Yang, Mingzhen
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [4] THE USE OF AZACITIDINE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA UNFIT FOR INTENSIVE TREATMENT OR RESISTANT TO CHEMOTHERAPY
    Alpoim, M.
    Pinto, R.
    Gomes, P.
    Amorim, M.
    Carneiro, A.
    Principe, F.
    Guimaraes, J.
    [J]. HAEMATOLOGICA, 2013, 98 : 533 - 534
  • [5] Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
    Leiming Xia
    Wanlu Tian
    Yiming Zhao
    Lingling Jiang
    Wei Qian
    Lei Jiang
    Ling Ge
    Jianjun Li
    Fengbo Jin
    Mingzhen Yang
    [J]. Signal Transduction and Targeted Therapy, 8
  • [6] EFFICACY OF DECITABINE IN 10-DAY REGIMEN IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA INELIGIBLE FOR INTENSIVE CHEMOTHERAPY
    Moreno de Gusmao, B.
    Esteves, I.
    Santos, F. P. S.
    Petrolli, M.
    Ferreira, F.
    Galvao, C., Jr.
    Perini, G.
    Hyppolito, J.
    Helman, R.
    Hamersclak, N.
    [J]. LEUKEMIA RESEARCH, 2015, 39 : S113 - S113
  • [7] EFFICACY OF DECITABINE IN 10-DAY REGIMEN IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA INELIGIBLE FOR INTENSIVE CHEMOTHERAPY
    Moreno De Gusmao, B.
    Esteves, I.
    Petrolli, M.
    Hyppolito, J.
    Santos, F.
    Ferreira, F.
    Perini, G.
    Helman, R.
    Hamerschlak, N.
    [J]. HAEMATOLOGICA, 2015, 100 : 653 - 653
  • [8] Combining Atovaquone with Intensive Conventional Chemotherapy for Pediatric Acute Myeloid Leukemia (AML) Is Feasible and Well Tolerated
    Stevens, Alexandra McLean
    Schafer, Eric
    Li, Minhua
    Terrell, Maci
    Rashid, Raushan
    Paek, Hana
    Weisnicht, Allison
    Keogh, J. Noah
    Alozie, Michelle C.
    Oviedo, Hailey H.
    Gonzalez, Alan K.
    Mangubat-Medina, Alicia
    Wang, Haopei
    Jo, Eunji
    Rabik, Cara A.
    Bocchini, Claire
    Hilsenbeck, Susan
    Ball, Zachary T.
    Cooper, Todd M.
    Redell, Michele
    [J]. BLOOD, 2021, 138
  • [9] Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
    Yamamoto, Kazuhito
    Shinagawa, Atsushi
    DiNardo, Courtney D.
    Pratz, Keith W.
    Ishizawa, Kenichi
    Miyamoto, Toshihiro
    Komatsu, Norio
    Nakashima, Yasuhiro
    Yoshida, Chikashi
    Fukuhara, Noriko
    Usuki, Kensuke
    Yamauchi, Takahiro
    Asada, Noboru
    Asou, Norio
    Choi, Ilseung
    Miyazaki, Yasushi
    Honda, Hideyuki
    Okubo, Sumiko
    Kurokawa, Misaki
    Zhou, Ying
    Zha, Jiuhong
    Potluri, Jalaja
    Matsumura, Itaru
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (01) : 29 - 38
  • [10] AZACITIDINE AND INTENSIVE CHEMOTHERAPY IN THE TREATMENT OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA: A META-ANALYSIS
    Gao, S.
    Su, L.
    Li, W.
    Li, Y.
    Yu, P.
    [J]. HAEMATOLOGICA, 2014, 99 : 34 - 34
12345